News Angle poised to take on US cancer diagnostics market Circulating tumour cell test could help select drug therapy.
News Theranos settles with investor on claims it lied about busin... Partner Fund Management agrees to drop lawsuits.
News Health insurer spots potential of Owlstone's lung cancer bre... The venture capital arm of the UK’s biggest insurance firm Aviva is to invest $5 million (£4m) in Owlstone Medical, one of the country’s most promising and potentially groundbreaking diagno
News 'Repeated violations' behind Theranos lab closure CMS report describes failures meeting its own quality control procedures.
News Abbott’s Zika blood test approved for emergency use Abbott's test is now the first to receive FDA commercial authorisation in an emergency use setting.
News Roche enters blood diagnostic market, promises faster result... Platform combines morphology analysis, cell counting and cell classification.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
